Dr. David Samadi: Pioneer in Men’s Health

Dr. David Samadi is a respected urologist specializing in urologic oncology. He has performed over 3000 robotic surgeries in treatment of prostate cancer. He currently serves as Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital in New York City. He also hosted Sunday Houscall, a medical advice show on the Fox News Channel from 2011-2016. The show continues as a live stream on drsamaditv.com every Sunday at 12:30 PM EST, and is also available on Dr. Samadi’s pages on Facebook, Twitter and YouTube.

Born in Iran in 1964, Dr. David Samadi left Iran in 1979. After attending school in Belgium and England, he went to high school in Rosslyn, New York. After receiving a degree in biochemistry from Stony Brook University in New York, he received his M.D. from the State University of New York, Stony Brook School of Medicine. He completed a residency in general surgery in 1996 from Montefiore Medical Center and a residency in urology in 2000 from Albert Einstein College of Medicine. He also completed a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center in 2001 and then a fellowship in laproscopic and robotic surgery from Henri Mondor Hospital in France in 2002.

One of Dr. David Samadi’s most noted achievements is the invention of the SMART technique (Samadi Modified Advanced Robotic Treatment) for the treatment of prostate cancer. In an interview published on Ideamensch.com on September 17, 2017, Dr. Samadi says that one of the main advantages of the SMART technique is that it uses robotic technology to separate the prostate from the surrounding nerves, avoiding serious side effects often suffered after traditional surgery such as incontinence and impotence.

Dr. Samadi has also received many awards for his work. He was recognized in the Best Doctors issue of New York Magazine five times from 2009-2015 and was named one of America’s Top Doctors and one of America’s Top Doctors for Cancer five times each. He has won five Patients’ Choice Awards, is a three-time recipient of the Most Compassionate Doctor award and an American Cancer Society Community Partner Award recipient.

In January 2018, Dr. David Samadi wrote about Mitt Romney’s successful prostate surgery. He said that Mitt Romney made the right choice in choosing surgery over radiation because of the better overall prognosis surgery provides. He also highlighted several other politicians who had received successful prostate surgery, including Colin Powell and John Kerry.

Dr. David Samadi info: www.roboticoncology.com/


Dr. David Samadi: Mitt Romney’s Cancer Prognosis good after Successful Surgery Treatment

The former Republican presidential nominee Mitt Romney recently revealed that he had undergone a prostate surgery treatment last summer. Dr. David Samadi had earlier been diagnosed with a slow-growing tumor which prompted him to seek medical attention. It is not very clear why the former presidential nominee made his health status public, but there are signs that he would vie for the Utah Senate position which will soon be left vacant by the current senator, Orrin Hatch.

Romney was treated at UC Irvin Hospital in California by DR. Thomas Ahlering who also performed the successful operation. According to a statement released by the hospital, Romney’s prognosis was good as he joined hundreds of thousands of other men diagnosed with prostate cancer in 2017. The American Cancer Society has estimated an increase in the number of new cancer cases in 2018.

Prostate cancer is usually associated with older men especially those from 65 years and above. Most men are often diagnosed at the age of 66. Mitt Romney turned 70 years in March 2017. Romney is however not the first politician to be successfully treated with surgery for prostate cancer. In 2003, Collin Powel, a former secretary of state went through a surgery where his prostate gland was removed at Walter Reed Army Medical Center. Also, after declaring his ambition to be one of the U.S presidential candidates, John Kerry got information that he had prostate cancer. He also underwent successful surgery and was healed.

There are always two major treatment options one can take after being diagnosed with prostate cancer, the first is surgery, and the other is radiation. Dr. David Samadi always advises his patients on both the pros and cons of each treatment method so that as they make a decision they fully understand what they are getting into.

Dr. David Samadi is the current chairman of urology and chief of robotic surgery at Lenox Hill Hospital in New York and has served in this position for over six years. Dr. Samadi went to Stony Brook University for his B.S and studied his M.D at Montefiore medical center. He has worked with several hospitals in the country and around the world. He is has conducted thousands of successful prostate operations. He recently developed Samadi Modern Advanced Robotic Technique (SMART) which aims at reducing side effects in prostate cancer treatment. The technique has already been tried and has been proven to work effectively.


Cancer Treatment Centers of America; Improving Treatment options for Cancer patients through Clinical Pathways program

Numerous oncologists were brought on board to develop the Clinical Pathways program. It provides a wide range of treatment options for cancer patients. NantHealth and Allscripts have joined hands with the Cancer Treatment Centers of America (CTCA) to ensure that this program is fully implemented to increase the efficiency of cancer treatment.

The Clinical Pathways program which contains a significant amount of data about cancer care was created to cater exclusively for the patient. It allows them to discuss possible treatment options with clinicians. Besides, it increases the confidence of the patient in whatever regimen that will be adopted. The clinical data in this system is sufficient to get insurance providers to release funds for the patients in good time.

An integrated solution to cancer treatment was at the back of the minds of the three organizations when the foundations of this project were put in place back in 2016. Paul Black, the CEO of Allscripts, states that this solution analyses clinical workflows as well as design sessions to better the process of selection and ordering of the chemotherapy regimen. It will inevitably improve the care that patients receive from CTCA.

Cancer Treatment Centers of America boast of advanced technology which they have put in place in the diagnosis and treatment of cancer. All the patients that find time to visit any of their five hospitals get personalized treatment. It depends on the unique nature of everyone’s state of health. Fatigue, nausea and pain, the side effects of cancer, are also managed to improve your response to cancer treatment.

CTCA provides a second option where possible treatment options will be offered once a full diagnostic evaluation has been done. The diagnostic tools used are barely invasive. Once you have chosen your preferred treatment option, treatment will begin. Chemotherapy, immunotherapy as well as surgery are used together in an integrated treatment model.

To Read More Click Here


A Quick Glance at Eric Lefkofsky

Eric Lefkofsky is among the few tycoons who are known for creating their wealth through legitimate means which not only benefit them but also the public in general. He did so while at Groupon and it seems he is not done yet. Eric Lefkofsky through Tempus where he is a co-founder is now on a mission to help save lives of cancer patients through genomic sequencing. The company which is headquartered in Chicago recently helped raise approximately $70 million from different investors. The cash raised in addition to the 130 million US dollars that he helped create, will increase the net worth of Tempus to around $700 million. To answer the question asked by many people regarding his new interest in health care, Eric says he was motivated after he oversaw the lack of the right facilities to treat cancer patients during the diagnosis of a loved one. Tempus combines the use of technology to put together all the clinical data of each patient. Through this, doctors will have access to first-hand information regarding each patient hence creating a more personalized treatment. That will contribute majorly in helping them gain access to better medical care. Also, it will transform the health sector which is known to have disorganized sets of information on the patients. In 2016. Tempus got into a partnership with several medical schools such as Duke University which will help it achieve its goal.

An in-depth view on Eric Lefkofsky

Known to many for his excellent entrepreneurial skills, Eric was born back in the year 1969 in September. He has had a hand in the establishment of various prominent companies such as Groupon, Echo Global Logistics, and many others. Eric Lefkofsky was born and brought up in Michigan and later went to the University of Michigan Law School where he graduated in 1993. Eric has had quite a high-flying career, and in addition to working with the firms mentioned at the beginning, he has co-founded several other companies. He is also a man known for his philanthropic nature, and through the Lefkofsky foundation, he supports other organizations which are in the course of charity. Eric is also a board member at Children’s Memorial Hospital and other public charities. He is a man of many capabilities as he is also a teacher and author.

To know more click here



Eric Lefkofsky Rise To A Better Tomorrow

Having started out his college years back in the year 1987, Eric Lefkofsky was a fine student at the University of Michigan as well as the University of Michigan Law School later on in the year 1991, where he achieved his JD in 1994 before going on to explore exciting world of business.

Jumping straight into the mix and groove of the business world, Eric Lefkofksy has always been an exceptional entrepreneur, taking his instincts as Eric Lefkofsky trusted compass, Lefkofsky soon after graduation developed and founded his very first company called InnerWorkings in May of 2001 where he also stood unsurprisingly as the company’s Chief Executive Officer.

Taking great pride in his creation, Lefkofsky stayed with his company for three years before deciding to make another splash, having thoroughly enjoyed the process of creating cancer treatment his own business in the past. His next entrepreneurial adventure was that of Echo Gloabl Logistics which he founded in February of 2005. Noticing quickly that he had developed a knack for creating businesses, in March of 2010 Eric Lefkofsky decided to follow his calling.

In June of 2006, Eric Lefkofsky founded Media Bank and later in 2010 after having left Echo Global Logistics, he also co-founded the company Lightbank, both of which he still to this day currently presides over claiming total fulfillment in his outstanding work at both companies. He is also currently the chairman and Co-founder of Groupon as well as the co-founder of Uptake, both of which he is also still very much so actively involved in to this present day.

With an abundance of outstanding expertise in his field of work in the business universe, Eric Lefkofsky is most notably recognized for his latest accomplishment as the Co-founder and Chief Executive Officer over the company Tempus, Inc., which is a technological company that combines an array of phenomenal sciences and technological discoveries to fight against cancer with a vengeance, desperate to discover better treatments and an eventual cure for the commonly fatal disease.

With an impressive background and an exceptional skill set and tenacity, EricLefkofsky is changing the future.

for more info: www.bizjournals.com/chicago/news/2017/04/12/groupon-co-founder-moves-to-help-youth-access-art.html


Cancer Treatment Centers of America Continue to Leverage Valuable Partnerships

In their quest to stay at the forefront of cancer treatment research and new developments, Cancer Treatment Centers of America recently formed a strategic partnership with NantHealth and Allscripts in order to provide physicians with the latest developments in cancer treatment options and research across various markets. When operating to its full extent, physicians will have everything needed at the point of care with the patient to make all appropriate decisions for their overall care. In addition, they will have access to any potential drug interactions that could occur as a result of a proposed treatment. It also enables them to look at the key differences between different treatment options, as well as cost differences by market.

Cancer Treatment Centers of America is a network of 5 hospitals in major cities across the United States including Philadelphia, Tulsa, Atlanta, Chicago and Phoenix. These highly specialized hospitals provide the most cutting edge cancer treatment available today by the most experienced and sought after oncologists in the country.

According to the article, “Cancer Treatment Centers of America® Partners with Allscripts and NantHealth to Launch Clinical Pathways, a Comprehensive and Custom Oncology Treatment Platform,” their headquarters is located in Boca Raton, FL. The network of highly specialized hospitals provides an integrative approach to the care of every patient that is centered around the individual and the treatment options that will best meet their specific needs. While focusing on cancer treatments and surgery, they also focus on effectively treating difficult side effects such as nausea, fatigue and pain. Before moving their headquarters to Boca Raton, Florida in 2015, The Cancer Treatment Centers of America was headquartered in Schaumburg, Illinois. They do not practice a cookie cutter approach to cancer, rather believe that each cancer is just as unique as the patient that is fighting it.

For more information follow CTCA on Twitter and Facebook.